This Article Free Full Text Free Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ligthart-Melis, G. C. Articles by van Leeuwen, P. A. M. Search for Related Content PubMed PubMed Citation Articles by Ligthart-Melis, G. C. Articles by van Leeuwen, P. A. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE Social Bookmarking                         What's this?

The Route of Administration (Enteral or Parenteral) Affects the Conversion of Isotopically Labeled L-[2-¹⁵N]Glutamine Into Citrulline and Arginine in Humans

Gerdien C. Ligthart-Melis, RD, MSc^*,, Marcel C. G. van de Poll, MD^,, Cornelis H. C. Dejong, MD, PhD, Petra G. Boelens, MD, PhD^*, Nicolaas E. P. Deutz, MD, PhD and Paul A. M. van Leeuwen, MD, PhD^*

From the ^* Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands; and the Department of Surgery, University Hospital Maastricht, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht, The Netherlands

Correspondence: Paul A. M. van Leeuwen, MD, PhD, Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands. Electronic mail may be sent to pam.vleeuwen{at}vumc.nl.

Background: Glutamine exhibits numerous beneficial effects in experimental and clinical studies. It has been suggested that these effects may be partly mediated by the conversion of glutamine into citrulline and arginine. The intestinal metabolism of glutamine appears to be crucial in this pathway. The present study was designed to establish the effect of the feeding route, enteral or parenteral, on the conversion of exogenously administered glutamine into citrulline and arginine at an organ level in humans, with a focus on gut metabolism. Methods: Sixteen patients undergoing upper gastrointestinal surgery received an IV or enteral (EN) infusion of L-[2-¹⁵N]glutamine. Blood was sampled from a radial artery and from the portal and right renal vein. Amino acid concentrations and enrichments were measured, and net fluxes of [¹⁵N]-labeled substrates across the portal drained viscera (PDV) and kidneys were calculated from arteriovenous differences and plasma flow. Results: Arterial [¹⁵N]glutamine enrichments were significantly lower during enteral tracer infusion (tracer-to-tracee ratio [labeled vs unlabeled substrate, TTR%] IV: 6.66 ± 0.35 vs EN: 3.04 ± 0.45; p < .01), reflecting first-pass intestinal metabolism of glutamine during absorption. Compared with IV administration, enteral administration of the glutamine tracer resulted in a significantly higher intestinal fractional extraction of [¹⁵N]glutamine (IV: 0.15 ± 0.03 vs EN: 0.44 ± 0.08 µmol/kg/h; p < .01). Furthermore, enteral administration of the glutamine tracer resulted in higher arterial enrichments of [¹⁵N]citrulline (TTR% IV: 5.52 ± 0.44 vs EN: 8.81 ± 1.1; p = .02), and both routes of administration generated a significant enrichment of [¹⁵N]arginine (TTR% IV: 1.43 ± 0.12 vs EN: 1.68 ± 0.18). This was accompanied by intestinal release of [¹⁵N]citrulline across the PDV, which was higher with enteral glutamine (IV: 0.38 ± 0.07 vs EN: 0.72 ± 0.11 µmol/kg/h; p = .02), and subsequent [¹⁵N]arginine release in both groups. Conclusions: In humans, the gut preferably takes up enterally administered glutamine compared with intravenously provided glutamine. The route of administration, enteral or IV, affects the quantitative conversion of glutamine into citrulline and subsequent renal arginine synthesis in humans.

Discussant

Author's Response

Journal of Parenteral and Enteral Nutrition, Vol. 31, No. 5, 343-350 (2007)
DOI: 10.1177/0148607107031005343


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. C Ligthart-Melis, M. C. van de Poll, M. A. Vermeulen, P. G Boelens, M P. van den Tol, C. van Schaik, J.-P. De Bandt, N. E. Deutz, C. H. Dejong, and P. A. van Leeuwen Enteral administration of alanyl-[2-15N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans Am. J. Clinical Nutrition, July 1, 2009; 90(1): 95 - 105. [Abstract] [Full Text] [PDF]

				R. F. Bertolo and D. G. Burrin Comparative Aspects of Tissue Glutamine and Proline Metabolism J. Nutr., October 1, 2008; 138(10): 2032S - 2039S. [Abstract] [Full Text] [PDF]

				H. E. Skillman and P. E. Wischmeyer Nutrition Therapy in Critically Ill Infants and Children JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 520 - 534. [Abstract] [Full Text] [PDF]

				G. C Ligthart-Melis, M. C. van de Poll, P. G Boelens, C. H. Dejong, N. E. Deutz, and P. A. van Leeuwen Glutamine is an important precursor for de novo synthesis of arginine in humans Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1282 - 1289. [Abstract] [Full Text] [PDF]